Rare diseases
Investigational molecules
Locations
Back to France1 537 clinical trials in Toulon, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
FranceA study of ficerafusp alfa and nivolumab in patients with head and neck cancer who did not respond to platinum-based chemotherapy.
FranceA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
FranceStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
FranceA study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
FranceComparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.
FranceA study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia
FranceA study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.
FranceStudy of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment
FranceStudy comparing firmonertinib with osimertinib or afatinib for patients with advanced lung cancer with uncommon EGFR mutations
FranceA Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
FranceA Study of Atumelnant for Children with Congenital Adrenal Hyperplasia
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer treatments, including innovative combination therapies and immunotherapy approaches. Multiple studies evaluating novel drug combinations to improve patient outcomes.
Research spans various disease stages and includes both early-stage and metastatic cancer treatments.
Studies investigating treatments for chronic lymphocytic leukemia and blood-related conditions. Research includes evaluation of novel drug combinations and targeted therapies.
Focus on improving treatment outcomes for previously untreated patients with coexisting conditions.
Investigations into stroke prevention and treatment of thrombotic conditions. Studies evaluating new anticoagulants and therapeutic approaches for various cardiovascular conditions.
Clinical trials examining innovative treatments for atrial fibrillation and deep vein thrombosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
